The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China ...

WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the deal ...

News that pharmaceutical company MSD Ireland has acquired the WuXi Vaccines manufacturing facility in Dundalk has been ...

Pharmaceutical giant Merck, which operates as MSD outside of the U.S., is to acquire the WuXi Vaccines manufacturing plant in Dundalk as part of a €500M deal, bringing the U.S.-based company ...

Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland. MSD said the deal is worth €500m and ...

The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American company says that in addition to the 150 jobs at the Dundalk facility ...

Laura Varley is a Careers reporter at Silicon Republic. She has a background in technology PR and journalism and is borderline obsessed with film and television, the theatre, Marvel and Mayo GAA ...

Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 ...

Healthcare company MSD Ireland has acquired the state-of -the art WuXoi manufacturing plant in Dundalk, with the official handover expecting to take place during the first half of 2025. It was ...

WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...